Medisafe ISO 13485:2016 Certificate

Medisafe Certification for Medical Device Quality Management Systems.

ISO 13485:2016Medisafe is ISO 13485:2016 certified, meeting all quality management system parameters specific to medical devices.

What’s the ISO?
The International Organization for Standardization (ISO) is an independent, non-governmental organization with a membership of 167 national standards bodies. It is based in Switzerland and develops voluntary, consensus-based, market relevant worldwide that support innovation and provide solutions to global challenges.

What’s “ISO 13485:2016 certified” mean?
This certification specifically sets out the quality management system parameters specific to medical devices, specifically with respect to risk management, safeguards and quality control in supply chain management. ISO 13485 is designed to be used by organizations involved in the design, production, installation and servicing of medical devices and related services. It can also be used by internal and external parties, such as certification bodies, to help them with their auditing processes.

Why was ISO 13485 recently updated and what are the main improvements?
All ISO standards are reviewed every five years to establish if a revision is required in order to keep it current and relevant for the marketplace. ISO 13485:2016 is designed to respond to the latest quality management system practices, including changes in technology and regulatory requirements and expectations. The new version has a greater emphasis on risk management and risk-based decision making, as well as changes related to the increased regulatory requirements for organizations in the supply chain.

How does this help Medisafe?
See more our ISO 13485:2016 announcement. 

Download our ISO 13485: 2016 Certificate

You may also like

80% Pharma Price Cuts? A New Era of Performance-Driven Patient Engagement for Agencies

The second half of 2025 brings an increasingly pressurized pharmaceutical landscape marked by potential federal mandates to slash US drug 

..Read More

Transforming Breast Cancer Care: Proven Adherence Gains for Pharma Execs

Summary Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 

..Read More

Medisafe Empowers Pharma: Elevating Cardiovascular Drug Launches

Summary The cardiovascular pharmaceutical landscape constantly encounters hurdles such as medication non-adherence and fragmented patient engagement. Medisafe’s pioneering digital solutions, 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.